Dan Dishner
Senior Vice President of Corporate Communications
Replay available
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Serge Belanger
Analyst, Needham & Company
Serena Chen
Analyst, Wells Fargo Securities
Jason Gerberry
Analyst, Bank of America
Ekaterina Niyakova
Analyst, JP Morgan
David Amsalon
Analyst, Piper Sandler
Tony Mars
Executive Vice President of Regulatory Affairs and Clinical Operations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amphastar Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.238 Please note that certain statements made during this call regarding matters that are 00:00:03.238 -- 00:00:07.809 not historical facts, including but not limited to management's outlook or predictions 00:00:07.809 -- 00:00:11.016 for future periods, are forward-looking statements. 00:00:11.016 -- 00:00:14.881 These statements are based solely on information that is now available to us. 00:00:14.881 -- 00:00:18.966 We encourage you to review the session entitled forward-looking statements in the press 00:00:18.966 -- 00:00:23.312 release issued today and the presentation on the company's website. 00:00:23.312 -- 00:00:28.198 Also, please refer to our SEC filings which can be found on our website and the SEC's 00:00:28.198 -- 00:00:33.324 website for a discussion of numerous factors that may impact our future performance. 00:00:33.324 -- 00:00:36.308 We will also discuss certain non-GAAP measures. 00:00:36.308 -- 00:00:39.892 Important information on our use of these measures and reconciliations to U.S. 00:00:39.892 -- 00:00:42.636 GAAP may be found in our earnings release. 00:00:42.636 -- 00:00:44.986 Please note this conference is being recorded. 00:00:44.986 -- 00:00:48.552 Our speakers today are Mr. Bill Peters, CFO, Mr. 00:00:48.552 -- 00:00:52.538 Dan Dishner, Senior Vice President of Corporate Communications, and Mr. 00:00:52.538 -- 00:00:57.807 Tony Mars, Executive Vice President of Regulatory Affairs and Clinical Operations. 00:00:57.807 -- 00:01:00.050 I will now turn the conference over to your host, Mr. 00:01:00.050 -- 00:01:03.797 Dan Dishner, Senior Vice President of Corporate Communications. 00:01:03.797 -- 00:01:06.261 Dan, you may begin. 00:01:06.261 -- 00:01:11.770 Thank you, Paul. Good afternoon, and thank you for ...